Reply to Zaragori et al.: “Is IDH mutation status associated with 18F-FDopa PET uptake”

被引:0
|
作者
Francesco Cicone
Luciano Carideo
Claudia Scaringi
Giuseppe Minniti
机构
[1] “Magna Graecia” University of Catanzaro,Unit of Nuclear Medicine, Department of Experimental and Clinical Medicine
[2] University Campus “Salvatore Venuta”,Unit of Nuclear Medicine, Sant’Andrea Hospital, Department of Surgical and Medical Sciences and Translational Medicine
[3] Sapienza University of Rome,Radiation Oncology Unit
[4] UPMC Hillman Cancer Center,Unit of Radiotherapy, Department of Medical, Surgical and Neuro Sciences
[5] San Pietro Hospital FBF,undefined
[6] University of Siena,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:230 / 231
页数:1
相关论文
共 50 条
  • [1] Reply to Zaragori et al.: "Is IDH mutation status associated with 18F-FDopa PET uptake"
    Cicone, Francesco
    Carideo, Luciano
    Scaringi, Claudia
    Minniti, Giuseppe
    ANNALS OF NUCLEAR MEDICINE, 2020, 34 (03) : 230 - 231
  • [2] Is IDH mutation status associated with 18F-FDopa PET uptake?
    Timothée Zaragori
    Eric Guedj
    Antoine Verger
    Annals of Nuclear Medicine, 2020, 34 : 228 - 229
  • [3] Is IDH mutation status associated with 18F-FDopa PET uptake?
    Zaragori, Timothee
    Guedj, Eric
    Verger, Antoine
    ANNALS OF NUCLEAR MEDICINE, 2020, 34 (03) : 228 - 229
  • [4] Uptake of 18F-FDOPA in the heart muscle of normal humans in 18F-FDOPA PET
    Kato, K.
    Abe, S.
    Odagawa, T.
    Niwa, A.
    Fujita, Y.
    Naganawa, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S447 - S448
  • [5] IDH mutation is paradoxically associated with higher 18F-FDOPA PET uptake in diffuse grade II and grade III gliomas
    Verger, A.
    Metellus, Ph.
    Sala, Q.
    Colin, C.
    Bialecki, E.
    Taieb, D.
    Chinot, O.
    Figarella-Branger, D.
    Guedj, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (08) : 1306 - 1311
  • [6] IDH mutation is paradoxically associated with higher 18F-FDOPA PET uptake in diffuse grade II and grade III gliomas
    A. Verger
    Ph. Metellus
    Q. Sala
    C. Colin
    E. Bialecki
    D. Taieb
    O. Chinot
    D. Figarella-Branger
    E. Guedj
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1306 - 1311
  • [7] LAT1 expression and 18F-FDOPA PET uptake correlate with IDH mutation status in recurrent high-grade gliomas
    Cobes, Nina
    Tran, Suzanne
    Mathon, Bertrand
    Nichelli, Lucia
    Bielle, Franck
    Touat, Mehdi
    Kas, Aurelie
    Rozenblum, Laura
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [8] 18F-FDOPA PET And IDH Mutation As Prognostic Factors Of Velocity Of Diameter Expansion In Newly Diagnosed
    Isal, S.
    Gauchotte, G.
    Rech, F.
    Blonski, M.
    Planel, S.
    Chawki, M.
    Karcher, G.
    Marie, P.
    Taillandier, L.
    Verger, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S640 - S640
  • [9] Gallbladder Paraganglioma Associated with SDHD Mutation: a Potential Pitfall on 18F-FDOPA PET Imaging
    Zahraa Abdul Sater
    Abhishek Jha
    Adel Mandl
    Sheila K. Mangelen
    Jorge A. Carrasquillo
    Alexander Ling
    Melissa K. Gonzales
    Osorio Lopes Abath Neto
    Markku Miettinen
    Karen T. Adams
    Pavel Nockel
    Mustapha El Lakis
    Karel Pacak
    Nuclear Medicine and Molecular Imaging, 2019, 53 : 144 - 147
  • [10] Gallbladder Paraganglioma Associated with SDHD Mutation: a Potential Pitfall on 18F-FDOPA PET Imaging
    Sater, Zahraa Abdul
    Jha, Abhishek
    Mandl, Adel
    Mangelen, Sheila K.
    Carrasquillo, Jorge A.
    Ling, Alexander
    Gonzales, Melissa K.
    Abath Neto, Osorio Lopes
    Miettinen, Markku
    Adams, Karen T.
    Nockel, Pavel
    El Lakis, Mustapha
    Pacak, Karel
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 53 (02) : 144 - 147